P2RX4 and ocular melanoma: The results revealed that the extent of co-expression of P2X4 with GFAP in the SG was increased in the OM group compared to the control group (p < 0.01), while treatment with P2X4 shRNA or imperatorin reduced such upregulated co-expression (p < 0.01).